We also noted that the glycolysis enzyme ENO1, which was transcriptionally enriched in the noninvasive phenotype and has been a target of interest for cancer drug development, has recently been shown to have an iron-regulatory role via modulating the degradation of ACO1.66 The gene discussed is ACO1; the disease is cancer.